IBANDROCARE 150 MG 2 TAB

* Ibandrocare (Ibandronic acid) 150 mg 2 Film-Coated Scored Tablets.
* Composition: Each film-coated scored tablet contains:
& Ibandronate sodium monohydrate 168.75 mg (Equivalent to Ibandronic acid 150 mg).
* Indications:
& Treatment and prevention of postmenopausal osteoporosis:
& IBANDROCARE is indicated for the treatment and prevention of osteoporosis in postmenopausal women.
& IBANDROCARE increases bone mineral density (BMD) and reduces the incidence of vertebral fractures.
* Dosage and mode of administration:
# Dose:
& The dose of IBANDROCARE is 150 mg F.C. Scored Tablet taken once monthly on the same date each month.
# Dosing instructions:
– To maximize absorption and clinical benefit, IBANDROCARE should be taken at least 60 minutes before the
& first food or drink (other than water) of the day or before taking any oral medication or supplementation
& including calcium, antacids, or vitamins.
– To facilitate delivery of the stomach and thus reduce the potential for esophageal irritation (Ibandrocare tablets
& should be swallowed whole with a full glass of plain water (6 to 8 oz) while the patient is standing or sitting in
& an upright position. Patients should not lie down for 60 minutes after taking Ibandrocare. Patients should not eat,
& drink anything except water, or take other medications for at least 60 minutes after taking Ibandrocare. Plain
& water is the only drink that should be taken with Ibandrocare. Note that some mineral waters may have a higher
& concentration of calcium and therefore should not be used. Patients should not chew or suck the tablet because
& of a potential for oropharyngeal ulceration. The Ibandrocare 150 mg tablet should be taken on the same date
& each month (i.e., the patient’s Ibandrocare day).
– The patient must not take two Ibandrocare 150 mg tablets within the same week.
– If the once-monthly dose is missed, and the patients next scheduled Ibandrocare day is more than 7 days away,
& the patient should be instructed to take IBANDROCARE 150 mg tablet in the morning following the date that it is
& remembered. The patient should then return to taking one IBANDROCARE 150 mg tablet every month in the
& morning of their chosen day, according to their original schedule.
– If the once-monthly dose is missed, and the patient’s next scheduled IBANDROCARE day is 1 to 7 days away
& the patient must wait until the subsequent month’s scheduled IBANDROCARE day to take their tablet. The patient
& should then return to taking one IBANDROCARE 150 mg tablet every month in the morning of their chosen day
& according to their original schedule.
# Recommendations for calcium and vitamin D supplementation:
& Patients should receive supplemental calcium and vitamin D if dietary intake is inadequate.